Insilico Medicine: Lessons in IP strategy from a front-runner in AI-drug discovery
http://ipkitten.blogspot.com/2025/02/insilico-medicine-lessons-in-ip.html The intersection of AI and pharmaceutical development presents unprecedented opportunities but also raises complex legal questions. Recent developments and successes in AI-drug discovery highlight some of the key IP issues in AI-drug development. Companies are being forced to tackle these issues head-on as the IP law advances almost as... Continue reading